Showing results (441-450 of 703) with videos related to
Sort By:
Pageof 71
BMC Health Services Research|September 8, 2012
Study protocol: to investigate effects of highly specialized rehabilitation for patients with multiple sclerosis. A randomized controlled trial of a personalized, multidisciplinary interventionJan Sørensen, Anne Lee, Brita Løvendahl, et al.Journal of Diabetes Science and Technology|December 23, 2022
Time for Using Machine Learning for Dose Guidance in Titration of People With Type 2 Diabetes? A Systematic Review of Basal Insulin Dose GuidanceCamilla Heisel Nyholm Thomsen, Stine Hangaard, Thomas Kronborg, et al.Diabetes Technology & Therapeutics|September 2, 2025
Biases in Glucose Metrics Are Directly Related to Low Coverage of Continuous Glucose Monitoring: Insights from Diverse PopulationsSimon Lebech Cichosz, Niels Væver Hartvig, Thomas Kronborg, et al.Journal of Diabetes Science and Technology|December 29, 2023
A Three-Step Data-Driven Methodology to Assess Adherence to Basal Insulin Therapy in Patients With Insulin-Treated Type 2 DiabetesJannie Toft Damsgaard Nørlev, Thomas Kronborg, Morten Hasselstrøm Jensen, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|October 7, 2017
Longer term effectiveness of inpatient multidisciplinary rehabilitation on health-related quality of life in MS patients: a pragmatic randomized controlled trial - The Danish MS Hospitals Rehabilitation StudyFinn Boesen, Michael Nørgaard, Philipp Trénel, et al.Journal of Diabetes Science and Technology|May 28, 2020
Smoking is Associated With Increased Risk of Not Achieving Glycemic Target, Increased Glycemic Variability, and Increased Risk of Hypoglycemia for People With Type 1 DiabetesMorten Hasselstrøm Jensen, Simon Lebech Cichosz, Irl B Hirsch, et al.Plos One|April 11, 2015
Biomarkers of inflammation and axonal degeneration/damage in patients with newly diagnosed multiple sclerosis: contributions of the soluble CD163 CSF/serum ratio to a biomarker panelMorten Stilund, Mikkel Carstensen Gjelstrup, Thor Petersen, et al.Journal of Diabetes|March 26, 2025
Diabetes Complications and Comorbidities as Risk Factors for MACE in People With Type 2 Diabetes and Their Development Over Time: A Danish Registry-Based Case-Control StudyAsger Ahlmann Bech, Mia Daugaard Madsen, Annika Vestergaard Kvist, et al.Plos One|June 3, 2014
Soluble CD163 as a marker of macrophage activity in newly diagnosed patients with multiple sclerosisMorten Stilund, Ann-Kathrin Reuschlein, Tove Christensen, et al.Studies in Health Technology and Informatics|August 23, 2024
Development of a Basal Insulin Titration System to Support Healthcare Providers in Treatment of People with Type 2 Diabetes: Preliminary ResultsCamilla H N Thomsen, Stine Hangaard, Thomas Kronborg, et al.Pageof 71